Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-24T12:09:33.440Z Has data issue: false hasContentIssue false

Elevated Levels of τ and Ubiquitin in Brain and Cerebrospinal Fluid in Alzheimer's Disease

Published online by Cambridge University Press:  10 January 2005

Khalid Iqbal
Affiliation:
New York Institute for Basic Research in Developmental Disabilities, Staten Island, New York, USA
Inge Grundke-Iqbal
Affiliation:
New York Institute for Basic Research in Developmental Disabilities, Staten Island, New York, USA

Abstract

Alzheimer's disease (AD) is histopathologically characterized by the presence of numerous neurons with neurofibrillary tangles of paired helical filaments (PHF) in the neocortex, particularly the hippocampus. The major protein subunit of PHF, which also accumulate as neuropil threads and dystrophic neurites of the neuritic (senile) plaques, is the microtubule-associated protein τ. τ in AD brain is abnormally hyperphosphorylated. In addition to hyperphosphorylation, some of the AD τ is also ubiquitinated. The level of τ in AD brain is elevated severalfold, and this increase is in the form of the abnormally phospholylated τ. The levels of conjugated ubiquitin are also increased severalfold in AD brain. The cerbrospinal fluid (CSF) levels of both τ and ubiquitin are elevated in AD. However, some of the normal elderly and non-AD neurological control cases also show elevated levels of these two proteins in the CSF. At present, it is not clear whether the overlap in CSF τ or ubiquitin values between AD and the control groups is due to some unknown heterogeneity of AD, inclusion of presymptomatic AD cases in the control group, or lack of specificity of the CSF elevation of these markers to AD. Thus, until the results of prospective studies on many patients with AD and normal controls become available, the CSF τ and ubiquitin levels can be used only as additional tools in the psychometric and clinical diagnosis of AD.

Type
Peripheral Markers
Copyright
© 1997 International Psychogeriatric Association

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)